Fosun Pharma Offloads 4.5% Stake in Gland Pharma

Chinese pharmaceutical major Fosun Pharma has sold a 4.5–4.55% stake in Hyderabad-based !GLAND Pharma for ₹2,121.5 crore through block deals on September 4, 2026. Fosun Pharma Industrial Pte Ltd, a wholly owned subsidiary of Shanghai Fosun Pharmaceutical and the promoter of Gland Pharma, offloaded 75.05 lakh shares (approximately 4.55% of the company) across multiple tranches. The shares changed hands at an average price of ₹2,826.60 each. The sale reduced Fosun’s holding from 51.77% (as of June 2026) to 47.22%, taking it below the 50% mark for the first time. Gland Pharma, a specialist in generic injectables and This marks Fosun’s second significant stake sale in the company in just over two years, following a 6% divestment in June 2024.